人工膵臓:医療機器パイプライン製品状況2021

◆英語タイトル:Artificial Pancreas - Medical Devices Pipeline Product Landscape, 2021
◆商品コード:GD21JU016
◆発行会社(リサーチ会社):GlobalData
◆発行日:2021年6月
◆ページ数:103
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グローバルデータ社の本調査レポートでは、人工膵臓の世界市場について調査し、イントロダクション、開発中製品、企業別分析、企業/製品概要、最近の動向などを掲載しています。

・イントロダクション
・開発中の人工膵臓
・人工膵臓の企業別分析
・人工膵臓の企業/製品概要
・最近の人工膵臓動向
【レポートの概要】

Artificial Pancreas – Medical Devices Pipeline Product Landscape, 2021
Summary

GlobalData’s Medical Devices sector report, “Artificial Pancreas – Medical Devices Pipeline Product Landscape, 2021″ provides comprehensive information about the Artificial Pancreas pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Artificial Pancreas helps people with diabetes, primarily type 1, automatically and continuously control their blood glucose level by providing the substitute endocrine functionality of a healthy pancreas.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Artificial Pancreas under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Artificial Pancreas and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Artificial Pancreas under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Artificial Pancreas Overview
3 Products under Development
3.1 Artificial Pancreas – Pipeline Products by Stage of Development
3.2 Artificial Pancreas – Pipeline Products by Territory
3.3 Artificial Pancreas – Pipeline Products by Regulatory Path
3.4 Artificial Pancreas – Pipeline Products by Estimated Approval Date
3.5 Artificial Pancreas – Ongoing Clinical Trials
4 Artificial Pancreas – Pipeline Products under Development by Companies
4.1 Artificial Pancreas Companies – Pipeline Products by Stage of Development
4.2 Artificial Pancreas – Pipeline Products by Stage of Development
5 Artificial Pancreas Companies and Product Overview
5.1 Admetsys Corp Company Overview
5.1.1 Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advanced Biosensors-Ohio LLC Company Overview
5.2.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
5.3 Beta Bionics Inc Company Overview
5.3.1 Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Beta-O2 Technologies Ltd Company Overview
5.4.1 Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Bigfoot Biomedical Inc Company Overview
5.5.1 Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 BioTex Inc Company Overview
5.6.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Cerco Medical LLC Company Overview
5.7.1 Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 Converge Biotech, Inc. Company Overview
5.8.1 Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Covalor Medical, LLC Company Overview
5.9.1 Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.10 De Montfort University Company Overview
5.10.1 De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
5.11 Debiotech SA Company Overview
5.11.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
5.12 Defymed SAS Company Overview
5.12.1 Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
5.13 Diabeloop SA Company Overview
5.13.1 Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview
5.14 EOFlow Co Ltd Company Overview
5.14.1 EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.15 Giner Inc Company Overview
5.15.1 Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
5.16 Harvard John A Paulson School of Engineering and Applied Sciences Company Overview
5.16.1 Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview
5.17 Healios Inc Company Overview
5.17.1 Healios Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Humacyte Inc Company Overview
5.18.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
5.19 Ideal Medical Technologies Inc Company Overview
5.19.1 Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Imperial College London Company Overview
5.20.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.21 Inreda Diabetic BV Company Overview
5.21.1 Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
5.22 Insulet Corp Company Overview
5.22.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
5.23 Joslin Diabetes Center Company Overview
5.23.1 Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview
5.24 Kencak LLC Company Overview
5.24.1 Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
5.25 McGill University Company Overview
5.25.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview
5.26 Medtronic Diabetes Company Overview
5.26.1 Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
5.27 Medtronic Inc Company Overview
5.27.1 Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
5.28 Miromatrix Medical Inc Company Overview
5.28.1 Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 Pacific Diabetes Technologies, Inc. Company Overview
5.29.1 Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.30 Pancreum, LLC Company Overview
5.30.1 Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
5.31 PharmaCyte Biotech Inc Company Overview
5.31.1 PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
5.32 Polytechnic University of Valencia Company Overview
5.32.1 Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
5.33 Rensselaer Polytechnic Institute Company Overview
5.33.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
5.34 Senseonics Holdings Inc Company Overview
5.34.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
5.35 Stanford University Company Overview
5.35.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.36 TecMed Inc Company Overview
5.36.1 TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.37 The Alfred Mann Foundation Company Overview
5.37.1 The Alfred Mann Foundation Pipeline Products & Ongoing Clinical Trials Overview
5.38 TypeZero Technologies LLC Company Overview
5.38.1 TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
5.39 U-Needle BV Company Overview
5.39.1 U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview
5.40 Universidad Autonoma de Madrid Company Overview
5.40.1 Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
5.41 University of California San Francisco Company Overview
5.41.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
5.42 University of California Santa Barbara Company Overview
5.42.1 University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
5.43 University of Cambridge Company Overview
5.43.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
5.44 University of Florida Company Overview
5.44.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview
5.45 University of Minnesota Company Overview
5.45.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.46 University of Newcastle Company Overview
5.46.1 University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
5.47 WaveForm Technologies Inc Company Overview
5.47.1 WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.48 XERIS Pharmaceuticals Inc Company Overview
5.48.1 XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.49 Yale University Company Overview
5.49.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview
6 Artificial Pancreas – Recent Developments
6.1 May 06, 2021: Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year
6.2 May 05, 2021: University of Cambridge appoints Dr Diarmuid O’Brien as new Chief Executive of Cambridge Enterprise
6.3 Apr 05, 2021: Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021
6.4 Mar 02, 2021: Xeris Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on March 9, 2021
6.5 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
6.6 Nov 09, 2020: Xeris Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020
6.7 Aug 06, 2020: Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Artificial Pancreas - Pipeline Products by Stage of Development
Artificial Pancreas - Pipeline Products by Territory
Artificial Pancreas - Pipeline Products by Regulatory Path
Artificial Pancreas - Pipeline Products by Estimated Approval Date
Artificial Pancreas - Ongoing Clinical Trials
Artificial Pancreas Companies - Pipeline Products by Stage of Development
Artificial Pancreas - Pipeline Products by Stage of Development
Admetsys Corp Pipeline Products & Ongoing Clinical Trials Overview
Smart Pancreas - Product Status
Smart Pancreas - Product Description
Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
Artificial Pancreas - Product Status
Artificial Pancreas - Product Description
Beta Bionics Inc Pipeline Products & Ongoing Clinical Trials Overview
Bihormonal iLet Bionic Pancreas - Product Status
Bihormonal iLet Bionic Pancreas - Product Description
Gen 2 GlucoSTAT - Product Status
Gen 2 GlucoSTAT - Product Description
Gen 4 iLet System - Product Status
Gen 4 iLet System - Product Description
iLet Bionic Pancreas - Glucagon-only - Product Status
iLet Bionic Pancreas - Glucagon-only - Product Description
iLet Bionic Pancreas - Insulin-only - Product Status
iLet Bionic Pancreas - Insulin-only - Product Description
Beta Bionics Inc - Ongoing Clinical Trials Overview
Bihormonal iLet Bionic Pancreas - Feasibility of Outpatient Automated Blood Glucose Control with the iLet Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes
iLet Bionic Pancreas - Insulin-only - Feasibility of Outpatient Automated Blood Glucose Control with the iLet Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes
iLet Bionic Pancreas - Insulin-only - Individualizing Automated Closed Loop Glucose Control through Pharmacokinetic Profiling in an Insulin-only Bionic Pancreas
iLet Bionic Pancreas - Insulin-only - The Insulin-only Bionic Pancreas Pivotal Trial: Testing the iLet in Adults and Children with Type 1 Diabetes
Beta-O2 Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
ßAir Bio-artificial Pancreas - Product Status
ßAir Bio-artificial Pancreas - Product Description
Beta-O2 Technologies Ltd - Ongoing Clinical Trials Overview
ßAir Bio-artificial Pancreas - An Open Label, Pilot Investigation, to Assess the Safety and Efficacy of Transplantation of Macro-encapsulated Human Islets within the Bioartificial Pancreas Beta-air in Patients with Type 1 Diabetes Mellitus
Bigfoot Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Bigfoot Smartloop System - Product Status
Bigfoot Smartloop System - Product Description
BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview
Artificial Pancreas - Product Status
Artificial Pancreas - Product Description
Cerco Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Bioartificial Pancreas - Product Status
Bioartificial Pancreas - Product Description
Converge Biotech, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Bioartificial Pancreas System - Product Status
Bioartificial Pancreas System - Product Description
Covalor Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview
Artificial Pancreas - Product Status
Artificial Pancreas - Product Description
De Montfort University Pipeline Products & Ongoing Clinical Trials Overview
InSmart Artificial Pancreas - Product Status
InSmart Artificial Pancreas - Product Description
Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview
Next Generation Artificial Pancreas - Product Status
Next Generation Artificial Pancreas - Product Description
Defymed SAS Pipeline Products & Ongoing Clinical Trials Overview
MAILPAN - Product Status
MAILPAN - Product Description
Diabeloop SA Pipeline Products & Ongoing Clinical Trials Overview
DBL-hu - Product Status
DBL-hu - Product Description
DBLG1 - Adults - Product Status
DBLG1 - Adults - Product Description
DBLG1 - Pediatric Version - Product Status
DBLG1 - Pediatric Version - Product Description
Diabeloop SA - Ongoing Clinical Trials Overview
DBLG1 - Adults - Observational Study of the Use of DBLG1 System in Real Life
EOFlow Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
EOPancreas - Product Status
EOPancreas - Product Description
EOPatchX - Product Status
EOPatchX - Product Description
Giner Inc Pipeline Products & Ongoing Clinical Trials Overview
BAPIOS System - Product Status
BAPIOS System - Product Description
Harvard John A Paulson School of Engineering and Applied Sciences Pipeline Products & Ongoing Clinical Trials Overview
Pregnancy-Specific Artificial Pancreas - Product Status
Pregnancy-Specific Artificial Pancreas - Product Description
Harvard John A Paulson School of Engineering and Applied Sciences - Ongoing Clinical Trials Overview
Pregnancy-Specific Artificial Pancreas - Observational Study of Patient Important Outcomes in Pregnant Patients with Type 1 Diabetes Mellitus on Insulin Pump
Healios Inc Pipeline Products & Ongoing Clinical Trials Overview
Bioengineered Pancreas - Product Status
Bioengineered Pancreas - Product Description
Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview
BioVascular Pancreas - Product Status
BioVascular Pancreas - Product Description
Ideal Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
FUSION System - Product Status
FUSION System - Product Description
Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Bio-inspired Artificial Pancreas - Product Status
Bio-inspired Artificial Pancreas - Product Description
Inreda Diabetic BV Pipeline Products & Ongoing Clinical Trials Overview
Bi-Hormonal Artificial Pancreas - Lighter Version - Product Status
Bi-Hormonal Artificial Pancreas - Lighter Version - Product Description
Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview
Omnipod 5 - Product Status
Omnipod 5 - Product Description
Insulet Corp - Ongoing Clinical Trials Overview
Omnipod 5 - Automated Insulin Delivery for Inpatients with DysGlycemia (AIDING) Feasibility Study
Omnipod 5 - Evaluating the Safety and Effectiveness of the Omnipod 5 Automated Insulin Delivery System in Patients with Type 2 Diabetes
Omnipod 5 - Evaluating the Safety and Effectiveness of the Omnipod Horizon Automated Glucose Control System in Children with Type 1 Diabetes Aged 2.0-5.9 Years: Preschool Cohort
Omnipod 5 - Evaluating the Safety and Effectiveness of the Omnipod Horizon Automated Glucose Control System in Patients with Type 1 Diabetes
Joslin Diabetes Center Pipeline Products & Ongoing Clinical Trials Overview
Closed-Loop Glucagon Delivery System - Product Status
Closed-Loop Glucagon Delivery System - Product Description
Kencak LLC Pipeline Products & Ongoing Clinical Trials Overview
BioArtificial Pancreas - Product Status
BioArtificial Pancreas - Product Description
McGill University Pipeline Products & Ongoing Clinical Trials Overview
Artificial Pancreas - Type 1 Diabetes - Product Status
Artificial Pancreas - Type 1 Diabetes - Product Description
Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview
Minimed 780G - Adults - Product Status
Minimed 780G - Adults - Product Description
Minimed 890G - Product Status
Minimed 890G - Product Description
Medtronic Diabetes - Ongoing Clinical Trials Overview
Minimed 780G - Adults - Advanced Hybrid Closed-Loop Treatment in Adults with Type 1 Diabetes Not Meeting Glycaemic Targets: A Randomized Controlled Trial - The Steno 780G Study
Minimed 780G - Adults - An 8-day Initiation Protocol of Advanced Hybrid Closed Loop System in Children and Adolescents with Diabetes Type 1 on Multiple Daily Insulin Injection
Minimed 780G - Adults - Closed-loop Insulin Delivery in Pregnant Women with Type 1 Diabetes: A Randomized Controlled Trial: The CRISTAL Study
Minimed 780G - Adults - Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects
Minimed 780G - Adults - The MiniMed 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects with Type 1 Diabetes in France: EQOL Study
Minimed 780G - Adults - Transition of Patients with T1D From Multiple Daily Injection (MDI) and Self-monitoring of Blood Glucose (SMBG) Directly to MiniMed 780G Advanced Hybrid Closed Loop (AHCL) System :Impact on Glucose Control and Quality of Life Measures
Medtronic Inc Pipeline Products & Ongoing Clinical Trials Overview
Third-Generation Artificial Pancreas System - Product Status
Third-Generation Artificial Pancreas System - Product Description
Miromatrix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Miro Pancreas - Product Status
Miro Pancreas - Product Description
Pacific Diabetes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
SynerG - Product Status
SynerG - Product Description
Pancreum, LLC Pipeline Products & Ongoing Clinical Trials Overview
Genesis Artificial Pancreas - Product Status
Genesis Artificial Pancreas - Product Description
PharmaCyte Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview
Bio-Artificial Pancreas - Product Status
Bio-Artificial Pancreas - Product Description
Polytechnic University of Valencia Pipeline Products & Ongoing Clinical Trials Overview
ClosedLoop 4Meal - Product Status
ClosedLoop 4Meal - Product Description
Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
Closed-Loop Artificial Pancreas System - Product Status
Closed-Loop Artificial Pancreas System - Product Description
Rensselaer Polytechnic Institute - Ongoing Clinical Trials Overview
Closed-Loop Artificial Pancreas System - Restoring Brain Metabolism and Function in Older Adult T1DM Patients Using an AP System
Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump - Product Status
Eversense CGM System Integrated With inControl And Accu-Chek Insight Insulin Pump - Product Description
Stanford University Pipeline Products & Ongoing Clinical Trials Overview
Artificial Pancreas Device - Product Status
Artificial Pancreas Device - Product Description
TecMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Artificial Pancreas - Product Status
Artificial Pancreas - Product Description
The Alfred Mann Foundation Pipeline Products & Ongoing Clinical Trials Overview
Implantable Artificial Pancreas Device - Product Status
Implantable Artificial Pancreas Device - Product Description
TypeZero Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
inControl - Product Status
inControl - Product Description
U-Needle BV Pipeline Products & Ongoing Clinical Trials Overview
Microneedle Artificial Pancreas - Product Status
Microneedle Artificial Pancreas - Product Description
Universidad Autonoma de Madrid Pipeline Products & Ongoing Clinical Trials Overview
Predictive Rule-Based Algorithm - Product Status
Predictive Rule-Based Algorithm - Product Description
University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
Implantable Bioartificial Pancreas - Product Status
Implantable Bioartificial Pancreas - Product Description
University of California Santa Barbara Pipeline Products & Ongoing Clinical Trials Overview
Closed-Loop Artificial Pancreas - Product Status
Closed-Loop Artificial Pancreas - Product Description
Pediatric Artificial Pancreas - Product Status
Pediatric Artificial Pancreas - Product Description
University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview
Florence D2A System - Product Status
Florence D2A System - Product Description
FlorenceM - Product Status
FlorenceM - Product Description
University of Florida Pipeline Products & Ongoing Clinical Trials Overview
Bioartificial Pancreas - Type 1 Diabetes - Product Status
Bioartificial Pancreas - Type 1 Diabetes - Product Description
University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
Implantable Microvalve Device - Product Status
Implantable Microvalve Device - Product Description
University of Newcastle Pipeline Products & Ongoing Clinical Trials Overview
Closed Glucose-Sensing Insulin-Delivery System - Product Status
Closed Glucose-Sensing Insulin-Delivery System - Product Description
WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Closed Loop Insulin Delivery Solution - Product Status
Closed Loop Insulin Delivery Solution - Product Description
XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
Bi-Hormonal Artificial Pancreas - Product Status
Bi-Hormonal Artificial Pancreas - Product Description
Yale University Pipeline Products & Ongoing Clinical Trials Overview
Automated Insulin Delivery System - Product Status
Automated Insulin Delivery System - Product Description
Glossary

List of Figures
Artificial Pancreas - Pipeline Products by Stage of Development
Artificial Pancreas - Pipeline Products by Territory
Artificial Pancreas - Pipeline Products by Regulatory Path
Artificial Pancreas - Pipeline Products by Estimated Approval Date
Artificial Pancreas - Ongoing Clinical Trials

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[人工膵臓:医療機器パイプライン製品状況2021]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆